Bhopal (Madhya Pradesh) [India], April 30 (ANI): A multicentric study on the use Mycobacterium w (Mw), heat-killed Mycobacterium indicus pranii, as an adjunct to the treatment of coronavirus is being conducted at AIIMS Bhopal with the approval of Drug Controller General of India.
Mumbai (Maharashtra) [India], April 30 (ANI): Glenmark Pharmaceuticals said on Thursday it has received approval from the Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir anti-viral tablets on COVID-19 patients.
New Delhi [India], April 20 (ANI): The Indian Council of Medical Research (ICMR) has received 99 applications for participation in "Randomized controlled study to assess the safety and efficacy of convalescent plasma to limit COVID-19 associated complications".
New Delhi [India], April 18 (ANI): In view of the COVID-19 pandemic, the country's top drug controller has granted permission for the import of drugs with residual shelf life less than 60 per cent under special conditions. This will be effective for a period of three months or till further o
New Delhi [India], April 17 (ANI): As many as 67 Indian firms have got approval from the Central Drug Standard Controller Organisation (CDSCO) for antibody rapid testing kits for testing COVID-19.
Dehradun (Uttarakhand) [India], April 14 (ANI): While the demand for hydroxychloroquine tablets keeps on rising worldwide, small pharmaceutical manufacturers in Haridwar have stopped producing the drug due to the sharp increase in the cost of raw materials, according to Anil Sharma, Presiden
Baddi (Himachal Pradesh) [India], April 11 (ANI): With the demand for hydroxychloroquine, an anti-malarial drug, rising substantially in the wake of coronavirus pandemic, efforts are being made to speed up its production in Himachal Pradesh.
New Delhi [India], April 3 (ANI): In the wake of coronavirus lockdown, the Central Drugs Controller has instructed all port offices of Central Drugs Standard Control Organization (CDCSO) to release the consignments of vaccines and critical in vitro diagnostics (IVDs) in public interest.
Srinagar (Jammu and Kashmir) [India], April 1 (ANI): The National Pharmaceutical Pricing Authority (NPPA) has set up a Price Monitoring and Resource Unit (PMRU) in Jammu and Kashmir. Till now, 11 states including Kerala, Odisha, Gujarat, Rajasthan, Punjab, Haryana, Nagaland, Tripura, Uttar P